UNH vs CRL
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Charles River Laboratories Inte, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | CRL |
|---|---|---|
| Price | $405.59 | $284.37 |
| Market cap | $364.06B | $13.70B |
| P/E ratio | 26.0 | — |
| ROE | 14.15% | -7.52% |
| Profit margin | 3.14% | -5.96% |
| Revenue growth | 0.40% | -2.70% |
| Dividend yield | 2.29% | — |
| Beta | 0.63 | 1.38 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs CRL in plain English
- UNH is the bigger company — about 26.6× the market cap of CRL.
- UNH earns a higher return on equity (14% vs -8%).
- UNH is growing revenue faster (0% vs -3%).
- UNH pays a dividend (2.29%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
CRL return calculator
See what $1,000 in Charles River Laboratories Inte would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.